Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome-Reference-Cited by-同舟云学术

Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome

Published:2006-05-01 Issue:5 Volume:91 Page:1741-1747
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Setji Tracy L.¹²,Holland Nicole D.³,Sanders Linda L.¹,Pereira Kathy C.¹²,Diehl Anna Mae¹⁴,Brown Ann J.¹²

Affiliation:

1. Department of Medicine (T.L.S., L.L.S., K.C.P., A.M.D., A.J.B.), Durham, North Carolina 27710

2. Division of Endocrinology (T.L.S., K.C.P., A.J.B.), Durham, North Carolina 27710

3. Duke University (N.D.H.), Durham, North Carolina 27710

4. Division of Gastroenterology (A.M.D.), Duke University Medical Center, Durham, North Carolina 27710

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/91/5/1741/9265465/jcem1741.pdf

Reference36 articles.

1. The prevalence and features of the polycystic ovary syndrome in an unselected population.;Azziz;J Clin Endocrinol Metab,2004

2. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.;Knochenhauer;J Clin Endocrinol Metab,1998

3. Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome.;Dunaif;Diabetes,1989

4. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.;Ehrmann;Diabetes Care,1999

5. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.;Legro;J Clin Endocrinol Metab,1999

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D;International Journal of Molecular Sciences;2024-06-07

2. Polycystic ovary syndrome in North America;Polycystic Ovary Syndrome;2024

3. Polycystic ovary syndrome and nonalcoholic fatty liver disease;Polycystic Ovary Syndrome;2024

4. Clinical features and presentation of polycystic ovary syndrome;Polycystic Ovary Syndrome;2024

5. Metabolic comorbidities, endocrine—Diabetes, polycystic ovarian syndrome, thyroid dysfunction;Metabolic Steatotic Liver Disease;2024